Free Trial

Rapport Therapeutics (RAPP) Institutional Ownership

Rapport Therapeutics logo
$11.32 -0.13 (-1.09%)
As of 10:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Rapport Therapeutics (NASDAQ:RAPP)

Number of
Institutional Buyers
(last 12 months)
43
Total
Institutional Inflows
(last 12 months)
$169.29M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$2.73M
Get RAPP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RAPP Institutional Buying and Selling by Quarter

Rapport Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2025Alps Advisors Inc.26,128$262K0.0%-11.7%0.072%
4/29/2025 Bank of New York Mellon Corp35,482$356K0.0%+77.7%0.097%
4/8/2025 Rhumbline Advisers14,358$144K0.0%+40.1%0.039%
4/8/2025 Catalyst Private Wealth LLC10,000$100K0.0%N/A0.027%
4/7/2025 GAMMA Investing LLC9,208$918K0.0%+91,980.0%0.025%
3/18/2025California State Teachers Retirement System8,571$152K0.0%+1,151.2%0.023%
2/17/2025Woodline Partners LP181,530$3.22M0.0%-2.7%0.496%
2/17/2025Deutsche Bank AG2,317$41K0.0%N/A0.006%
2/17/2025Crestline Management LP27,496$488K0.0%N/A0.075%
2/17/2025Bank of America Corp DE6,578$117K0.0%-65.6%0.018%
2/17/2025Acuta Capital Partners LLC16,400$291K0.3%-6.8%0.045%
2/14/2025Virtus ETF Advisers LLC3,740$66K0.0%N/A0.010%
2/14/2025T. Rowe Price Investment Management Inc.1,636,931$29.04M0.0%-5.2%4.475%
2/14/2025Price T Rowe Associates Inc. MD1,143,384$20.29M0.0%+9.2%3.126%
2/14/2025TRV GP V LLC7,135,233$126.58M43.1%N/A19.506%
2/14/2025TRV GP VI LLC969,218$17.19M14.7%N/A2.650%
2/13/2025Barclays PLC18,497$328K0.0%+43.8%0.051%
2/13/2025Legal & General Group Plc9,523$169K0.0%+947.6%0.026%
2/13/2025Wells Fargo & Company MN4,824$86K0.0%+38.9%0.013%
2/12/2025Geode Capital Management LLC210,676$3.74M0.0%+4.4%0.576%
2/12/2025Alliancebernstein L.P.1,098,415$19.49M0.0%+0.9%3.003%
2/12/2025Norges Bank48,452$860K0.0%N/A0.132%
2/12/2025JPMorgan Chase & Co.7,170$127K0.0%+77.8%0.020%
2/11/2025KLP Kapitalforvaltning AS1,900$34K0.0%N/A0.005%
2/10/2025Swiss National Bank18,000$319K0.0%N/A0.049%
1/31/2025New York State Common Retirement Fund3,500$62K0.0%N/A0.010%
1/30/2025 Rhumbline Advisers10,249$182K0.0%-35.3%0.028%
1/24/2025Jennison Associates LLC62,287$1.11M0.0%N/A0.170%
1/24/2025China Universal Asset Management Co. Ltd.7,756$138K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.4,033$83K0.0%N/A0.011%
11/19/2024Barclays PLC12,863$264K0.0%+36.8%0.035%
11/16/2024Geode Capital Management LLC201,748$4.13M0.0%N/A0.552%
11/15/2024Barclays PLC12,863$264K0.0%+36.8%0.035%
11/15/2024State Street Corp58,046$1.19M0.0%N/A0.159%
11/15/2024Maven Securities LTD29,930$613K0.0%N/A0.082%
11/14/2024Eventide Asset Management LLC110,401$2.26M0.0%+120.8%0.302%
11/14/2024Acuta Capital Partners LLC17,600$360K0.3%-12.0%0.048%
11/14/2024MetLife Investment Management LLC5,710$117K0.0%N/A0.016%
11/13/2024BNP Paribas Financial Markets1,684$34K0.0%N/A0.005%
11/13/2024FMR LLC5,486,468$112.36M0.0%+10.1%14.999%
What President Trump’s Executive Order 14154 means for your money (Ad)

Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.

But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi
11/13/2024The Manufacturers Life Insurance Company77,344$1.58M0.0%+2.4%0.211%
11/12/2024Charles Schwab Investment Management Inc.73,146$1.50M0.0%N/A0.200%
11/7/2024LMR Partners LLP20,000$410K0.0%-60.0%0.055%
10/23/2024Values First Advisors Inc.1,507$31K0.0%N/A0.004%
10/3/2024 SG Americas Securities LLC4,934$101K0.0%N/A0.014%
8/27/2024Logos Global Management LP208,910$4.86M0.4%N/A0.591%
8/16/2024Perceptive Advisors LLC748,183$17.40M0.4%N/A2.045%
8/15/2024The Manufacturers Life Insurance Company75,516$1.76M0.0%N/A0.206%
8/15/2024Millennium Management LLC116,782$2.72M0.0%N/A0.319%
8/14/2024Squarepoint Ops LLC16,345$380K0.0%N/A0.045%
8/14/2024Sandia Investment Management LP5,000$116K0.2%N/A0.014%
8/14/2024ARCH Venture Management LLC3,728,738$86.73M31.6%N/A10.193%
8/14/2024Davidson Kempner Capital Management LP10,000$229K0.0%N/A0.027%
8/10/2024Sofinnova Investments Inc.1,951,562$45.39M2.4%N/A5.516%
8/9/2024Johnson & Johnson2,498,051$58.11M14.5%N/A7.061%
8/3/2024TD Asset Management Inc101,522$2.36M0.0%N/A0.287%
(Data available from 1/1/2016 forward)

RAPP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RAPP shares?

During the previous two years, 49 institutional investors and hedge funds held shares of Rapport Therapeutics. The most heavily invested institutionals were TRV GP V LLC ($126.58M), FMR LLC ($112.36M), ARCH Venture Management LLC ($86.73M), Johnson & Johnson ($58.11M), Sofinnova Investments Inc. ($45.39M), T. Rowe Price Investment Management Inc. ($29.04M), and Price T Rowe Associates Inc. MD ($20.29M).Learn more on RAPP's institutional investors.

Which institutional investors have been buying Rapport Therapeutics stock?

Of the 43 institutional investors that purchased Rapport Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP V LLC ($7.14M), ARCH Venture Management LLC ($3.73M), Johnson & Johnson ($2.50M), Sofinnova Investments Inc. ($1.95M), TRV GP VI LLC ($969.22K), Perceptive Advisors LLC ($748.18K), and FMR LLC ($503.12K).

How much institutional buying is happening at Rapport Therapeutics?

Institutional investors have bought a total of 18,873,360 shares in the last 24 months. This purchase volume represents approximately $169.29M in transactions.

Which Rapport Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Rapport Therapeutics stock in the last 24 months: T. Rowe Price Investment Management Inc. ($90.18K), LMR Partners LLP ($30K), Bank of America Corp DE ($12.53K), Rhumbline Advisers ($5.59K), Woodline Partners LP ($5.03K), Acuta Capital Partners LLC ($3.60K), and Alps Advisors Inc. ($3.45K).

How much institutional selling is happening at Rapport Therapeutics?

Institutional investors have sold a total of 150,388 shares in the last 24 months. This volume of shares sold represents approximately $2.73M in transactions.



This page (NASDAQ:RAPP) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners